Trend
DailyUptrend (confirmed)
4 hourStrong Bearish
1 hourStrong Bearish
15 minDescending Triangle
5 minStrong Bearish
Daily trend turns down below $55.44
Key levels
Resistance$68.95
Resistance$64.33
Support$60.20
Support$55.44
Latest news & SEC filings
EarningsInsplorion Posts Q3 2026 Results
ProductInspire Medical Systems wins FDA approval for pediatric Down syndrome use
AnalystUBS Revises Its Target Price for Inspire Medical Systems
All INSP news →Inspire Medical Systems is a medical technology company that develops and sells neurostimulation devices for obstructive sleep apnea. Its Inspire system is an implanted, closed-loop device that stimulates the hypoglossal nerve so the airway stays unobstructed while a person sleeps, offered as an alternative for patients who cannot tolerate CPAP. The company sells to surgical facilities across North America, Europe and Asia, using its own sales force in some markets and distributors in others.
Based on the company's 10-K filed Feb 13, 2026.
NYSE · Healthcare
SEPT Low Target
$52.70
SEPT Mid Target
$62.00
SEPT High Target
$71.30
Analyst Consensus
$62.00
Thesis
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for INSP.
Start Free Trial →Valuation Verdict
OVERVALUED
Methods Used
P/E Forward, P/B, PEG, Analyst Consensus
Fair Value
$54.94
72
Moat Score
WIDE
7/9
Piotroski Score
11.5
Altman Z-Score
Insider Signal
NEUTRAL
0 buys / 2 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
DISTRIBUTING
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Ellis Gary Lee | director | Buy | 431 | $29K | Oct 14, 2026 |
| CARREL MICHAEL H | director | Buy | 203 | $14K | Oct 14, 2026 |
| Broader Shelley G | director | Buy | 284 | $19K | Oct 14, 2026 |
| Melenikiotou Georgia | director | Buy | 255 | $17K | Oct 14, 2026 |
| Kelly Jason P | officer | Buy | 6,350 | - | Aug 31, 2026 |
| Rondoni John | officer | Sale | 2,641 | $114K | May 15, 2026 |
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →Revenue YoY
13.6%
3yr Revenue CAGR
N/A%
EPS Growth YoY
179.43%
FCF Growth YoY
-13.9%
Revenue Trend
STRONG
SEPT Investing tracks real-time dark pool institutional trades for INSP, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:08:01 | $60.54 | 10,011 | $$606K | SELL |
| 21:00:38 | $60.54 | 1,072 | $$65K | SELL |
| 21:00:37 | $60.54 | 2,588 | $$157K | SELL |
| 21:00:37 | $60.54 | 2,658 | $$161K | SELL |
| 21:00:37 | $60.54 | 2,000 | $$121K | SELL |
5 dark pool trades shown · $$1.1M preview volume
Real-time institutional flow, block trades, and net positioning
SEPT Investing provides real-time options flow tracking for INSP, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| PUT | $60 | Dec 17 | 400 | $$4880 | 4 | SWEEP |
| PUT | $60 | Dec 17 | 400 | $$4880 | 4 | SWEEP |
| PUT | $60 | Dec 17 | 400 | $$2440 | 2 | SWEEP |
| PUT | $60 | Dec 17 | 400 | $$2440 | 2 | SWEEP |
| PUT | $60 | Dec 17 | 400 | $$2440 | 2 | SWEEP |
5 options trades shown · 0% calls
Unusual activity, GEX levels, max pain, and dealer positioning
SEPT's Trading AI has generated a free, downloadable PDF research report for Inspire Medical Systems, Inc. (INSP) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →Inspire Medical Systems, Inc. (INSP) is at $60.54, down 2.53% (-$1.57) at the Nov 12, 2026 close.
Latest INSP news — Nov 9, 2026: Insplorion Posts Q3 2026 Results · Nov 6, 2026: Inspire Medical Systems wins FDA approval for pediatric Down syndrome use
The average analyst price target for INSP is $62.00, ranging from $54 to $97, based on 13 analysts. Latest: Barclays initiates on Oct 7, 2026.
Analyst ratings for INSP: 1 Buy, 23 Hold, 1 Sell — consensus Hold.
INSP last reported on Aug 3, 2026: EPS $0.14 vs -$0.27 expected — a beat of 151.9%.
INSP trades at a P/E of 14.3.
INSP does not currently pay a dividend.
Support: $60.20, $55.44, $51.63. Resistance: $64.33, $68.95, $73.29.
Insider activity: NEUTRAL, 0 buys and 2 sells in the last 90 days.
Nov 9, 2026: Insplorion Posts Q3 2026 Results · Nov 6, 2026: Inspire Medical Systems wins FDA approval for pediatric Down syndrome use · Nov 6, 2026: UBS Revises Its Target Price for Inspire Medical Systems